Brightstone Capital

Brightstone Venture Capital is a Minneapolis-based venture capital firm founded in 1985 that specializes in early-stage and early-growth investments within the technology and life sciences sectors. The firm focuses on high-potential companies in the Upper Midwest, particularly Minnesota, providing capital and strategic guidance through its partners' extensive operating experience. In the healthcare space, Brightstone targets medical technology, biotechnology systems, and healthcare services, with a portfolio that has included notable exits such as AppTec Laboratory Services and Definity Health. The firm currently manages multiple funds, including its $100 million BVC2 fund, to support innovative startups in fields ranging from personalized medicine to medical devices.